Stockreport

GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance [Yahoo! Finance]

Vir Biotechnology, Inc.  (VIR) 
PDF Core earnings rose 16% year over year on a reported basis and 28% at a constant exchange rate (CER). Quarterly revenues increased 6% on a reported basis and 10% at CER [Read more]